San Sebastián, Basque Country, Spain
Our group at CIC biomaGUNE is engaged in both basic and applied research in Glycoscience, the science and technology of carbohydrates. Glycoscience is still a relatively understudied area but has a strong potential to provide groundbreaking solutions to major societal challenges in personalized medicine, gene therapy, biopharmaceuticals, food and biomaterials. In our research we focus specifically on biomedical glycoscience, investigating and exploiting structure and function of carbohydrates in the context of human biology and disease. We do this by developing specific tools for glycan analysis and glycan-based intervention and by closely collaborating with a growing number of internationally recognized researchers. for more information and access to recent publications please visit our research group website at www.glycotechnology.net From 2020-2024 I have also been CEO of Asparia Glycomics, which I co-founded in 2016. At Asparia we are helping companies to discover opportunities in glycoscience for their own R+D. We offer custom synthesis services for complex glycans, consulting and R+D services for glycan-based targeting, patented precision glycan analysis and microarray based glycomics services. Since 2024 I have moved to the role of CSO to be able to focus on the scientific development at Asparia. For more information see: www.aspariaglycomics.com
Development of kits for quantitative LC-MS based metabolomics
Development of semi-synthetic therapeutic glycoproteins